← All organizations
Highest phase reached
Phase 3
First clinical trial
Mar 1, 2011Last known activity
Jan 6, 2025
Timeline
2000s
- Dec 1, 2007
InflaRx GmbH— Founded
Drugs by trial phase (4 distinct, 15 trials)
Phase 3 (1 own, 0 via acquisition)
Phase 2 (3 own, 0 via acquisition)
Indications
Recent trials (19)
- NCT06701669CollaboratorPhase 2Jan 6, 2025
- NCT06701682CollaboratorPhase 2Dec 27, 2024
- NCT06701656CollaboratorPhase 2Dec 20, 2024
- NCT06703073CollaboratorPhase 2Dec 20, 2024
- NCT05964413Lead sponsorPhase 3Aug 15, 2023
- NCT04812535Lead sponsorPhase 2Jun 1, 2021
- NCT04333420Lead sponsorPhase 2/Phase 3Mar 31, 2020
- NCT03971643Study directorPhase 2May 31, 2019
- NCT03971643Lead sponsorPhase 2May 31, 2019
- NCT03895801Study directorPhase 2Mar 22, 2019
- NCT03895801Lead sponsorPhase 2Mar 22, 2019
- NCT03712345Lead sponsorPhase 2Oct 15, 2018
- NCT03712345Study directorPhase 2Oct 15, 2018
- NCT03487276Study directorPhase 2Feb 26, 2018
- NCT03487276Lead sponsorPhase 2Feb 26, 2018
Details
- Founded
- Jena, DE Dec 1, 2007
- Last known activity
- Jan 6, 2025